Cordani sells 201.9K CI shares for $59.1M under pre-arranged 10b5-1 plan; retains 57.8K shares
David Cordani, Chairman & CEO of Cigna Group, executed 13 sales totaling 201,878 shares for $59,114,186.29 on May 12, 2026, pursuant to a pre-arranged 10b5-1 trading plan adopted on 2026-02-06—making this a scheduled, non-discretionary transaction rather than a signal of conviction or concern. While Cordani's prior 19 sell transactions across all tickers achieved an 88.89% well-timed rate at the 90-day mark, the recent stock performance context matters: CI is trading at $294.93, down 13.0% from its 52-week high of $338.89, though up 8.2% over the past 30 days and 1.2% over 90 days. Post-transaction, Cordani retains 57,766 shares, demonstrating continued skin-in-the-game, and Cigna's fundamentals remain solid with $68.5B in annual revenue, $1.7B net income, 11.2% YoY revenue growth, and a 12.41 P/E ratio. The pre-arranged plan status limits the signaling power of this sale for inferring current insider sentiment.